Compare Five Below Inc (FIVE) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five Below Inc vs Zoetis Inc — how do they compare? Five Below Inc trades at $200.7 (market cap $10.67B), while Zoetis Inc trades at $77.31 (market cap $31.25B). The key difference: Zoetis Inc is far larger — about 2.9× Five Below Inc's market cap, and Zoetis Inc pays a 2.84% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| FIVE | ZTS | |
|---|---|---|
Market Cap | $10.67B | $31.25B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $156.76 |
52-Week Low | $131.94 | $71.91 |
Enterprise Value | $11.56B | $38.54B |
Dividend Yield | — | 2.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five Below (FIVE) trades at $200.59, up 3.87% today, with a bullish technical signal despite mixed moving averages. The company shows strong revenue growth, rising from $2.8B in 2022 to $3.88B in 2025, and has consistently beaten earnings expectations in recent quarters. Positive sentiment is driven by store expansion and digital marketing initiatives, with 60% of analysts rating it a Buy.
The outlook is favorable with a consensus price target of $252.09, implying 26% upside, supported by robust growth projections. Risks include competitive pressures and execution challenges in expansion. Net cash flow improved to $152M in 2025, but profit margins have fluctuated, requiring monitoring of cost management.
Zoetis (ZTS) trades at $77.13, up 4.12% in the last session, with a bearish technical signal from moving averages. The company reported strong 2025 results, including $9.47B revenue and $2.67B net income, with high profitability margins. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU. Cash flow improved to a positive $325M in 2025, though net cash flow is projected to decline in 2026.
The stock presents a mixed outlook: strong fundamentals and a consensus price target of $101.43 suggest upside, but legal risks and bearish technicals pose near-term headwinds. Earnings momentum is key, with Q2 2026 results critical after a Q1 miss. Institutional sentiment is cautious despite no sell ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
